MRI safety of a programmable shunt assistant at 3 and 7 Tesla

References

• Aschoff A, Kremer P, Hashemi B, Kunze S. The scientific history of hydrocephalus and its treatment. Neurosurg Rev 1999;22(2–3): 67–93.
   PubMed Web of Science ®Google Scholar
• Hofstetter T, Mirzayan MJ, Krauss JK. Ventriculoperitoneal shunt dysfunction in a patient presenting with neurogenic pulmonary edema. Case report. J Neurosurg 2007;106(4):701–3.
   PubMed Web of Science ®Google Scholar
• Mirzayan MJ, Koenig K, Bastuerk M, Krauss JK. Coma due to meteorism and increased intra-abdominal pressure subsequent to ventriculoperitoneal shunt dysfunction. Lancet 2006;368(9551):2032.
   PubMed Web of Science ®Google Scholar
• Pollack IF, Albright AL, Adelson PD. A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group. Neurosurgery 1999;45(6):1399–408.
   PubMed Web of Science ®Google Scholar
• Aschoff A, Kremer P, Benesch C, Fruh K, Klank A, Kunze S. Overdrainage and shunt technology. A critical comparison of programmable, hydrostatic and variable-resistance valves and flow-reducing devices. Childs Nerv Syst 1995;11(4):193–202.
   PubMed Web of Science ®Google Scholar
• Czosnyka ZH, Czosnyka M, Richards HK, Pickard JD. Evaluation of three new models of hydrocephalus shunts. Acta Neurochir Suppl 2005;95:223–7.
   PubMedGoogle Scholar
• Kremer P, Aschoff A, Kunze S. Risks of using siphon-reducing devices. Childs Nerv Syst 1994;10(4):231–5.
   PubMed Web of Science ®Google Scholar
• Ringel F, Schramm J, Meyer B. Comparison of programmable shunt valves vs standard valves for communicating hydrocephalus of adults: a retrospective analysis of 407 patients. Surg Neurol 2005;63(1):36–41.
   PubMedGoogle Scholar
• Rohde V, Haberl EJ, Ludwig H, Thomale UW. First experiences with an adjustable gravitational valve in childhood hydrocephalus. J Neurosurg Pediatr 2009;3(2):90–3.
   PubMed Web of Science ®Google Scholar
• Lavinio A, Harding S, Van Der BF, . Magnetic field interactions in adjustable hydrocephalus shunts. J Neurosurg Pediatr 2008;2(3):222–8.
   PubMed Web of Science ®Google Scholar
• Ludemann W, Rosahl SK, Kaminsky J, Samii M. Reliability of a new adjustable shunt device without the need for readjustment following 3-Tesla MRI. Childs Nerv Syst 2005;21(3):227–9.
   PubMed Web of Science ®Google Scholar
• Miwa K, Kondo H, Sakai N. Pressure changes observed in Codman-Medos programmable valves following magnetic exposure and filliping. Childs Nerv Syst 2001;17(3):150–3.
   PubMed Web of Science ®Google Scholar
• Shellock FG, Habibi R, Knebel J. Programmable CSF shunt valve: In vitro assessment of MR imaging safety at 3T. AJNR Am J Neuroradiol 2006;27(3):661–5.
   PubMed Web of Science ®Google Scholar
• Inoue T, Kuzu Y, Ogasawara K, Ogawa A. Effect of 3-tesla magnetic resonance imaging on various pressure programmable shunt valves. J Neurosurg 2005;103(2 Suppl):163–5.
   PubMed Web of Science ®Google Scholar
• Krauss JK, Regel JP, Vach W, . White matter lesions in patients with idiopathic normal pressure hydrocephalus and in an age-matched control group: A comparative study. Neurosurgery 1997;40(3):491–5.
   PubMed Web of Science ®Google Scholar
• Krauss JK, Regel JP, Vach W, Jungling FD, Droste DW, Wakhloo AK. Flow void of cerebrospinal fluid in idiopathic normal pressure hydrocephalus of the elderly: can it predict outcome after shunting? Neurosurgery 1997;40(1):67–73.
   PubMedGoogle Scholar
• Ortler M, Kostron H, Felber S. Transcutaneous pressure-adjustable valves and magnetic resonance imaging: an ex vivo examination of the Codman-Medos programmable valve and the Sophy adjustable pressure valve. Neurosurgery 1997;40(5):1050–7.
   PubMed Web of Science ®Google Scholar
• Mirzayan MJ, Luetjens G, Borremans J, Regel J, Krauss J. Extended long-term (> 5 years) outcome of cerebrospinal fluid shunting in idiopathic normal pressure hydrocephalus. Neurosurgery 2010;67(2):295–301.
   PubMed Web of Science ®Google Scholar
• Krauss JK, Halve B. Normal pressure hydrocephalus: survey on contemporary diagnostic algorithms and therapeutic decision-making in clinical practice. Acta Neurochir (Wien) 2004;146(4):379–88.
   PubMed Web of Science ®Google Scholar
• Fransen P. Transcutaneous pressure-adjustable valves and magnetic resonance imaging: an ex vivo examination of the Codman-Medos programmable valve and the Sophy adjustable pressure valve. Neurosurgery 1998;42(2):430.
   PubMed Web of Science ®Google Scholar
• Fransen P, Dooms G, Thauvoy C. Safety of the adjustable pressure ventricular valve in magnetic resonance imaging: problems and solutions. Neuroradiology 1992;34(6):508–9.
   PubMed Web of Science ®Google Scholar
• Lindner D, Preul C, Trantakis C, Moeller H, Meixensberger J. Effect of 3T MRI on the function of shunt valves—evaluation of Paedi GAV, Dual Switch and proGAV. Eur J Radiol 2005;56(1):56–9.
   PubMed Web of Science ®Google Scholar
• Shellock FG, Wilson SF, Mauge CP. Magnetically programmable shunt valve: MRI at 3-Tesla. Magn Reson Imaging 2007;25(7):1116–21.
   PubMed Web of Science ®Google Scholar
• Anderson R, Walker M, Viner J, Kestle J. Adjustment and malfunction of a programmable valve after exposure to toy magnets. J Neurosurg 2004;101(2 Suppl):222–5.
   PubMed Web of Science ®Google Scholar
• Schneider T, Knauff U, Nitsch J, Firsching R. Electromagnetic field hazards involving adjustable shunt valves in hydrocephalus. J Neurosurg 2002;96(2):331–4.
   PubMed Web of Science ®Google Scholar
• Shellock FG, Crues J. MR procedures: biologic effects, safety, and patient care. Radiology 2004;232:635–652.
   PubMed Web of Science ®Google Scholar
• Sprung C, Schlosser HG, Lemcke J, . The adjustable proGAV-shunt: A prospective safety and reliability multicenter study. Neurosurgery 2010;66(3):465–74.
   PubMed Web of Science ®Google Scholar
• American Society for Testing and Materials (ASTM). Designation: F 2052. Standard test method for measurement of magnetically induced displacement force on passive implants in the magnetic resonance environment. In: Annual book of ASTM standards. Section 13: Medical devices and services. West Conshohocken. PA: ASTM; 2002, 2009.
   Google Scholar
• Shellock FG. Biomedical Implants and Devices: Assessment of magnetic field interactions with a 3.0-Tesla MR system. J Magn Reson Imaging 2002;16:721–32.
   PubMed Web of Science ®Google Scholar